BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7530800)

  • 1. Prescriber guidelines improve initiation of anticoagulation.
    Dartnell JG; Allen B; McGrath KM; Moulds RF
    Med J Aust; 1995 Jan; 162(2):70-3. PubMed ID: 7530800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An evaluation and improvement program for inpatient anticoagulant control.
    Phillips WS; Smith J; Greaves M; Preston FE; Channer KS
    Thromb Haemost; 1997 Feb; 77(2):283-8. PubMed ID: 9157582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of early versus late initiation of warfarin during heparin therapy in acute thromboembolism.
    Mohiuddin SM; Hilleman DE; Destache CJ; Stoysich AM; Gannon JM; Sketch MH
    Am Heart J; 1992 Mar; 123(3):729-32. PubMed ID: 1539524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapy of acute thromboembolism with heparin and warfarin.
    Carter BL
    Clin Pharm; 1991 Jul; 10(7):503-18. PubMed ID: 1860301
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation. Current approach to heparin and warfarin therapy.
    Painter TD
    Postgrad Med; 1983 Sep; 74(3):341-5, 348, 350. PubMed ID: 6889207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of a bolus of intravenous heparin while initiating heparin therapy in anticoagulation following transient ischemic attack or stroke does not lead to increased morbidity or mortality.
    Toth C
    Blood Coagul Fibrinolysis; 2003 Jul; 14(5):463-8. PubMed ID: 12851532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparin monitoring and patient safety: a College of American Pathologists Q-Probes study of 3431 patients at 140 institutions.
    Valenstein PN; Walsh MK; Meier F;
    Arch Pathol Lab Med; 2004 Apr; 128(4):397-402. PubMed ID: 15043451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Challenges to the effective use of unfractionated heparin in the hospitalized management of acute thrombosis.
    Hylek EM; Regan S; Henault LE; Gardner M; Chan AT; Singer DE; Barry MJ
    Arch Intern Med; 2003 Mar; 163(5):621-7. PubMed ID: 12622610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review of the initiation of anticoagulant therapy.
    Corbett NE; Peterson GM
    J Clin Pharm Ther; 1995 Aug; 20(4):221-4. PubMed ID: 8557786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Post-operative heparin may not be required for transitioning patients with a HeartMate II left ventricular assist system to long-term warfarin therapy.
    Slaughter MS; Naka Y; John R; Boyle A; Conte JV; Russell SD; Aaronson KD; Sundareswaran KS; Farrar DJ; Pagani FD
    J Heart Lung Transplant; 2010 Jun; 29(6):616-24. PubMed ID: 20400335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimal therapeutic level of heparin therapy in patients with venous thrombosis.
    Hull RD; Raskob GE; Rosenbloom D; Lemaire J; Pineo GF; Baylis B; Ginsberg JS; Panju AA; Brill-Edwards P; Brant R
    Arch Intern Med; 1992 Aug; 152(8):1589-95. PubMed ID: 1497392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation in pregnancy with mechanical heart valves: 10-year experience.
    Akhtar RP; Abid AR; Zafar H; Cheema MA; Khan JS
    Asian Cardiovasc Thorac Ann; 2007 Dec; 15(6):497-501. PubMed ID: 18042775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-factor Xa and activated partial thromboplastin time measurements for heparin monitoring in mechanical circulatory support.
    Adatya S; Uriel N; Yarmohammadi H; Holley CT; Feng A; Roy SS; Reding MT; John R; Eckman P; Zantek ND
    JACC Heart Fail; 2015 Apr; 3(4):314-22. PubMed ID: 25770404
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the risks of anticoagulation therapy following experimental craniotomy in the rat.
    Schaible KL; Smith LJ; Fessler RG; Rachlin JR; Brown FD; Mullan S
    J Neurosurg; 1985 Dec; 63(6):959-62. PubMed ID: 4056909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of implementing the weight-based heparin nomogram as a practice guideline.
    Raschke RA; Gollihare B; Peirce JC
    Arch Intern Med; 1996 Aug 12-26; 156(15):1645-9. PubMed ID: 8694662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized, multicenter trial of weight-adjusted intravenous heparin dose titration and point-of-care coagulation monitoring in hospitalized patients with active thromboembolic disease. Antithrombotic Therapy Consortium Investigators.
    Becker RC; Ball SP; Eisenberg P; Borzak S; Held AC; Spencer F; Voyce SJ; Jesse R; Hendel R; Ma Y; Hurley T; Hebert J
    Am Heart J; 1999 Jan; 137(1):59-71. PubMed ID: 9878937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Audit of start of anticoagulation treatment in inpatients.
    Tan G; Cohen H; Taylor F; Gabbay J
    J Clin Pathol; 1993 Jan; 46(1):67-71. PubMed ID: 8432893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of venous thromboembolic disease. A pragmatic approach to anticoagulation and thrombolysis.
    Linn BJ; Mazza JJ; Friedenberg WR
    Postgrad Med; 1986 May; 79(6):171-80. PubMed ID: 3703754
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current concepts in anticoagulant therapy.
    Litin SC; Gastineau DA
    Mayo Clin Proc; 1995 Mar; 70(3):266-72. PubMed ID: 7861815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.